The Expression Patterns of Human Parkin in E. codi and Mammalian Cells
![]() |
Nam Min-Kyung
(Department of Biomedical Sciences, Research Institute of Molecular Genetics, the Catholic University of Korea)
Park Hye-Min (School of Life Science and Biotechnology, Korea University) Choi Ju-Youn (Research Insitute of Molecular Genetics, the Catholic University of Korea) Park Hyo-Jin (Research Institute of Molecular Genetics, The Catholic University of Korea, School of Life Science and Biotechnology, Korea University) Chung Kwang Chul (Department of Biology, College of Sciences, Yonsei University) Kang Seong man (School of Life Science and Biotechnology, Korea University) Rhim Hyangshuk (Department of Biomedical Sciences, Research Institute of Molecular Genetics, the Catholic University of Korea) |
1 | Huynh D. P., D. R. Scoles, D. Nguyen, S. M. Pulst. 2003. The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI. Hum Mol Genet. 12, 2587-2597 DOI ScienceOn |
2 | Ren Y., J. Zhao, J. Feng. 2003. Parkin binds to alpha/beta tubulin and increases their ubiquitination and degradation. J Neurosci.23, 3316-3324 |
3 | Zhang Y., J. Gao, K. K. Chung, H. Huang, V. L. Dawson, T. M. Dawson. 2000. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA. 97, 13354-13359 |
4 | Seong Y. M., H. J. Park, G. H Seong, J. Y. Choi, S. J. Yoon, B. R. Min, S. Kang and H. Rhim. 2004. N-terminal truncation circumvents proteolytic degradation of the human HtrA2/0mi serine protease in Escherichia coli: rapid purification of a proteolyticaTIy active HtrA2/Omi. Protein Expr Purif. 33, 200-208 DOI ScienceOn |
5 | Huynh D. P., M. Dy, D. Nguyen, T. R. Kiehl, S. M. Pulst. 2001. Differential expression and tissue distribution of parkin isoforms during mouse development. Brain Res Dev Brain Res. 130, 173-181 DOI ScienceOn |
6 | Kuhn K, X. R. Zhu, H. Lubbert and C. C. Stichel. 2004. Parkin expression in the developing mouse. Brain Res Dev Brain Res. 149, 131-142 DOI ScienceOn |
7 | Dagata V. and C. Sebastiano. 2004. Parkin transcript variants in rat and human brain. Neurochemical Research. 29, 1715-1724 DOI ScienceOn |
8 | Rechsteiner M. and S. W. Rogers. 1996. PEST sequences and regulation by proteolysis. Trends Biochem Sci. 21, 267271 |
9 | Murby M., M. Uhlen M and S. Stahl. 1996. Upstream strategies to minimize proteolytic degradation upon recombinant production in Escherichia coli. Protein Expr Purif. 7, 129-136 DOI ScienceOn |
10 | Mizuno Y., N. Hattori, H. Mori, T. Suzuki and K. Tanaka. 2001. Parkin and Parkinson's disease. Curr Opin Neurol. 14, 477-482 DOI ScienceOn |
11 | Tsai Y. C. P. S. Fishman, N. V. Thakor and G. A. Oyler 2003. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Bioi Chem. 278, 22044-22055 DOI ScienceOn |
12 | McClellan A. J., S. Tam, D. Kaganovich and J. Frydman. 2005. Protein quality control: chaperones culling corrupt conformations. Nat Cell BioI. 71 736-741 |
13 | Ardley H. C., C. C. Hung, and P. A. Robinson. 2005. The aggravating role of the ubiquitin-proteasome system in neurodegeneration. FEBS Lett. 579, 571-576 DOI ScienceOn |
14 | Shimura H., N. Hattori, S. Kubo, Y. Mizuno,S. Asakawa, S. Minoshima, N. Shimizu, K. Iwai, T. Chiba, K. Tanaka and T. Suzuki. 2000. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 25, 302-305 DOI ScienceOn |
15 | Morett E. and P. Bork P. 1999. A novel transactivation domain in parkin. Trends Biochem Sci. 24, 229-231 DOI ScienceOn |
16 | Choi P., H. Snyder, L. Petrucelli, C. Theisler, M. Chong, Y. Zhang, K. Lim, K. K. Chung, K. Kehoe, L. D' Adamio, J. M. Lee, E. Cochran, R. Bowser, T. M. Dawson and B. Wolozin. 2003. SEPT5_v2 is a parkin-binding protein. Brain Res Mol Brain Res. 117, 179-189 DOI ScienceOn |
17 | Corti O., C. Hampe, H. Koutnikova, F. Darios, S. Jacquier, A. Prigent, J. C. Robinson, L. Pradier, M. Ruberg, M. Mirande, E. Hirsch, T. Rooney, A. Fournier and A. Brice. 2003. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration. Hum Mol Genet. 12, 1427-1437 DOI ScienceOn |
18 | Gandhi S. and N. W. Wood. 2005. Molecular pathogenesis of Parkinson's disease. Hum Mol Genet. 14, 2749-2755 DOI ScienceOn |
19 | Cyr D. M., J. Hohfeld, and C.Patterson. 2002. Protein quality control: Ll-box-containing E3 ubiquitin ligases join the fold. Trends Biochem Sci. 27, 368-375 DOI ScienceOn |
20 | Hershko A. and A. Ciechanover. 1998. The ubiquitin system. Annu Rev Biochem. 67, 425-479 DOI ScienceOn |
21 | Tanaka K. and T. Chiba. 1998. The proteasome: a protein-destroying machine. Genes Cells. 3, 499-510 DOI ScienceOn |
22 | Frydman J. 2001. Folding of newly translated proteins in vivo: the role of molecular chaperones. Annu Rev Biochem. 70, 603-647 DOI ScienceOn |
23 | Finney N., F. Walther, P. Y. Mantel, D. Stauffer, G. Rovelli and K. K. Dev. 2003. The cellular protein level of parkin is regulated by its ubiquitin-like domain. J Bioi Chem. 278, 16054-1608 DOI ScienceOn |
24 | Lim K. L., K. C. Chew, J. M. Tan, C. Wang, K. K. Chung, Y. Zhang, Y. Tanaka, W. Smith, S. Engelender, C. A.Ross, V. L. Dawson and T. M. Dawson. 2005. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-l: implications for Lewy body formation. J Neurosci. 25, 2002-2009 DOI ScienceOn |
25 | Korhonen L.and D. Lindholm. 2004. The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle. J Cell Biol. 165, 27-30 DOI ScienceOn |
26 | Kim H. S., J. S. Yoo, Y. G. Kim, C. H. Chung and Y. L. Choi. 1999. Cloning and Expression of Serratia marcescens Coenzyme A (CoA) Transferase Gene in E. coli. J. Life Science. 9, 54-57 |
![]() |